ArticleSSM - population health2025
Association between stock market volatility and severe mental disorders: a multi-city time-series study.
Article in SSM - population health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Stock market volatility was commonly considered as a psychological stressor. However, the association between stock market volatility and severe mental disorders (SMD) has not been investigated. Methods: Daily numbers of SMD hospital admissions and Shanghai Stock Exchange Composite (SSEC) Index in 7 cities in southwestern China from 2020 to 2023 were collected. A two-stage time-series analysis was conducted to reveal the association between stock volatility and the risk of hospital admission for SMD. Stratified analyses were performed by age, gender, and ICD-10 codes to explore potential high-risk groups. Results: The association between the SSEC percentage change, SSEC closing price and SMD hospital admissions both exhibit a U-shaped curve. A 1 % decrease in SSEC is associated with a 7.2 % (95 %CI: 4.1 %-10.4 %) increase in the SMD admission, while a 1 % increase in SSEC is associated with a 2.6 % (95 %CI: 0.1 %-5.2 %) increase in the SMD admissions. With 3400 points as the dividing point, every 10-point increase in SSEC closing price is associated with a 9 % (95 %CI: 3.6 %-14.7 %) increase in the SMD hospital admissions, while each 10-point decrease is associated with a 4.4 % (95 %CI: 0.6 %-8.3 %) increase in the SMD hospital admissions. Furthermore, these associations tended to be stronger in the female and non-schizophrenia patients. Conclusion: These associations indicate that both rise and fall in stock prices increase the risk of SMD. This finding suggests that it is an effective way to take the stock speculation behavior into consideration when managing and treating the SMD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.